We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The International Vaccine Institute, with a $34 million grant from the Samsung Foundation to support development in the field, is fully funding the Inovio-GeneOne Korean trial.
Hyundai Pharm has filed for the marketing approval of Natesto, a nasal gel formulation of testosterone, with South Korea’s Ministry of Food and Drug Safety (MFDS).
The exclusive ten-year agreement includes a minimum of $2 million per year in sales of Zestra to the Company for a total of $20 million over the life of the ten-year term of the agreement